Home > Insider Trading > Dermira Inc.

Dermira Inc. (DERM)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

Displaying 9

Journey Medical Corporation (NASDAQ:DERM) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to Journey Medical’s Third Quarter 2023 Financial Results and Corporate Update Conference Call.

Keep Reading →

November 12th, 2023 - News Transcripts

Journey Medical Corporation (NASDAQ:DERM) Q2 2023 Earnings Call Transcript

Operator: Ladies and Gentleman, thank you for standing by. Good afternoon and welcome to Journey Medical Second Quarter 2023 Financial Results and Corporate Update conference call.

Keep Reading →

August 15th, 2023 - News Transcripts

Journey Medical Corporation (NASDAQ:DERM) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical's First Quarter 2023 Financial Results and Corporate Update Conference Call.

Keep Reading →

May 24th, 2023 - News Transcripts

Journey Medical Corporation (NASDAQ:DERM) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by.

Keep Reading →

April 1st, 2023 - News Transcripts

Here's What Hedge Funds Think About Dermira Inc (DERM)

Is Dermira Inc (NASDAQ:DERM) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.

Keep Reading →

December 8th, 2019 - Hedge Funds News

Do Hedge Funds Love Dermira Inc (DERM)?

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in October due to various reasons.

Keep Reading →

December 18th, 2018 - Hedge Funds News

Market Movers Today: Dermira Inc (DERM), Intrepid Potash, Inc. (IPI), XL Group Ltd (XL), Sparton Corporation (SPA), and More

In a major surprise for Dermira Inc. and Wall Street alike, Dermira’s acne drug failed to meet the co-primary endpoints of two important, late-stage clinical trials.

Keep Reading →

March 5th, 2018 - Market Movers News

Should You Buy Dermira Inc (DERM)?

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...

Keep Reading →

December 14th, 2016 - Hedge Funds News

Dermira Inc (DERM): Are Hedge Funds Right About This Stock?

After several tireless days, we have finished crunching the numbers from more than 700 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

Keep Reading →

November 25th, 2015 - Hedge Funds News